Effect of rituximab on pulmonary function in patients with rheumatoid arthritis
Conclusion Although no cases of symptomatic lung injury were observed, the progressive DLCO decline seems to indicate the presence of subclinical RTX-induced pulmonary toxicity.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Arthritis | Cancer & Oncology | Carbon Monoxide Poisoning | Drugs & Pharmacology | Lymphoma | Prednisone | Respiratory Medicine | Rheumatoid Arthritis | Rheumatology | Rituxan | Smokers | Spirometry | Toxicology